reason report
volum pt
bottom line report mix earn morn
remain confid sever opportun long-
term success follow anim health spin view
guidanc conserv due part slight slowdown
dental market base discuss medacorp
dental offic believ state stock market impact
patient volum peopl see save increas
like dental work done assum market
continu rise dental volum may re-acceler
similar februari adj ep guidanc
reflect growth rate compar adj ep
continu oper exclud anim health
view conserv appear well posit
invest growth area move forward given dividend
anim health spin use pay debt
dental slowdown disappoint face
tough comp equip sale believ end-market remain
rel healthi maintain op adjust pt
reflect quarter anim health spin
believ guidanc bottom line growth conserv
manag expect adj ep grow high singl digit
guid base continu oper exclud anim health
busi spun februari guidanc bottom-
end compani long-term expect high singl low
doubl digit growth call manag suggest
growth expect low singl digit acceler
remaind year view acceler favor
recogn order achiev guid rang growth may
actual surpass head
slow dental growth appear rebound na
dental intern sale growth y/i signific slowdown
global dental saw local
intern growth rate y/i
manag highlight soft end market novemb
decemb manag suggest rel soft
continu januari howev begin februari seen
realli nice pickup opinion possibl stock
market declin caus slowdown patient visit
market recov dispos incom increas patient volum
began grow
net debt total capit
price-to-earnings lt ep growth
year price history/av daili volume mil
compani inform svb leerink llc research
revenu billion dollar
ep adjust non-recur item restat account anim health spin
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
manag conserv manag mention
expect includ reflect recent soft
tri remain conserv determin whether anomali
go stick around coupl quarter dental growth
strong past quarter recent quarter draw
concern howev note rel low growth
follow strong sequenti rebound
respect
encourag manag three leg strategi
growth first continu advanc distribut
busi second invest expand presenc valu ad
servic third partner broad set manufactur
build brand equiti focu expand product
margin encourag manag comment regard
success build brand equiti specif area
look act one stop shop product oral
surgeri orthodont see initi driver
goal bp oper margin expans longer term
navig transit year follow anim health
medic technolog saw strong growth rate quarter
global medic sale increas y/i driven intern
growth acquisit growth fx loss off-set
global technolog revenu increas driven growth
acquisit intern growth partial
off-set headwind fx loss encourag
see overal growth segment outsid core
busi shift lower cost ambulatori site care continu
drive volum
look key long-term growth driver
focus improv practic effici effect
product drive smart patient commun
behalf practic engag patient encourag addit
visit treatment perform manag believ
averag dental offic might close year worth
bill diagnos treatment plan patient return
platform also includ product assist patient financ
insur program see signific
value- add dentist manag believ top prioriti
patient traffic demand
manag highlight success china compani
ten year built base anoth
close shortli like compani establish root china
ensur right infrastructur financi regulatori legal purpos
look grow organ area
expans includ brazil south africa area southeast
asia compani pursu integr acquisit organ
growth revenu remain small emerg market howev offer
growth potenti compani move forward
tweak estim maintain op updat model
reflect anim health spin-off continu believ
earn could see boost capit deploy either share
repurchas updat pt
reflect quarter anim health spin maintain
inc one largest distributor medic dental veterinari suppli
office-bas practic throughout world major compani busi base
dental suppli physician offic practic distributor north america
europ australia/new zealand dental anim health market enjoy top
qualiti servic mark custom medacorp survey organ growth
rate sever compani divis modest recent reacceler make us
posit compani on-going acquisit strategi drive accret
furthermor expect multipl compress stock experienc recent
month revers investor realiz margin distant threat worri
around ftc suit wane continu solid execut quarterli result time result
sentiment shift multipl expans trough level result rate share
current trade ep premium drug
distribut pharmaci group next month
expect share trade ep would put stock
price target valuat would slightli stock year histor
averag ntm ep therefor reason view especi given hsic
consist abil grow market share deliv upsid expect acquisit
believ current multipl reflect improv sentiment risk/reward
profil improv substanti
competit relianc manufactur healthcar distribut industri north
america intern highli competit distributor compet basi price
product offer custom servic valu ad product servic competitor obtain
exclus right manufactur distribut certain product manufactur bypass
distributor altogeth could advers impact earn larg competitor
especi abroad use size increas price pressur group purchas
organ gpo larg provid may also demand lower price addit
manufactur disrupt shortag result unabl meet custom
demand certain product seen flu vaccin shortag issu
supplier relationship advers impact firm earn
acquisit restructur one largest player alternate-car market
made numer acquisit domest intern market
acquisit joint ventur involv numer risk may integr well
manag intend success integr acquisit past
immedi short-term impact bottom line drag earn year
come acquisit may result loss custom product line acquir busi
may unintend effect area oper cost increas relat
restructur integr new busi advers impact firm
earn margin
season quarterli fluctuat tradit sale higher third
fourth quarter result end year custom purchas pattern well flu
season ill quarterli earn impact number factor includ
sever flu season product avail time price chang product releas
vendor advers impact revenu firm
govern regul healthcar reform custom
healthcar industri highli regul local state feder law firm may need
adapt procedur price result polici chang govern agenc
pressur reduc budget deficit balloon healthcar cost frequent target
enact healthcar reform reduct reimburs rate public and/or
privat insur program could advers impact revenu profit margin foreign
domest tax law also subject chang current interpret subject
scrutini challeng could advers impact firm earn
ftc litig su ftc alleg price collus
believ like outcom complaint settlement possibl
complaint could expand grow crimin charg expand area
revenu
revenu
revenu
net sale
adjust incom tax
incom tax
equiti incom affili
adjust incom cont op
net incom cont op
ep continu oper
adjust ep continu oper
restat annual quarter account anim health spin
